Trade Ideas August 10, 2026 03:53 AM

Buy L3Harris Now: Ride the Missile-and-Munitions Cycle as Backlogs Turn Into Revenue

Practical trade plan: enter near $288, protect downside, capture the defense procurement upswing

By Priya Menon
Share
Twitter Reddit Facebook LinkedIn
LHX

L3Harris sits squarely in the crosshairs of a defense spending rerating: strong backlog across missiles, sensors and battlefield communications, a high-margin propulsion business (Aerojet Rocketdyne), and healthy free cash flow. At $288 the stock offers asymmetric upside into persistent geopolitical-driven procurement tailwinds while trading at reasonable multiples given steady cash generation and a manageable balance sheet.

Buy L3Harris Now: Ride the Missile-and-Munitions Cycle as Backlogs Turn Into Revenue
LHX
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • L3Harris benefits directly from missile, interceptor and munitions procurement ramps and holds a critical propulsion business (Aerojet Rocketdyne).
  • Solid cash generation: free cash flow roughly $2.8B with a manageable debt-to-equity ratio (~0.55).
  • Valuation near 28x earnings reflects quality but leaves room to re-rate if multi-year DoD production converts to revenue.
  • Actionable trade: entry $288.17, stop $268.00, target $340.00, horizon long term (180 trading days).

Hook / Thesis

L3Harris (LHX) is my top tactical buy in aerospace & defense right now. The company sits at the intersection of three fast-growing pockets of defense procurement: missiles/propulsion, battlefield communications, and space/ISR systems. Recent headlines around Middle East tension and announced multi-year U.S. agreements to expand interceptor and munitions capacity have brought renewed visibility to the revenue pipeline for prime and subsystem suppliers. That’s a classic setup where backlog converts into outsized earnings and cash flow for well-positioned industrials.

At the current price of $288.17 L3Harris is trading off its spring highs but well above the July washout low. The shares already reflect a mature business with solid margins - price-to-earnings in the high 20s, free cash flow north of $2.8 billion, and leverage comfortably below 1x equity. This trade is about buying a high-quality defense operator while the market re-rates defense budgets and near-term production ramps.

Why the market should care - business snapshot and fundamental driver

L3Harris is a diversified defense and aerospace systems company operating across Communication Systems, Integrated Mission Systems, Space and Airborne Systems, and Aerojet Rocketdyne (propulsion, power and armament). The Aerojet Rocketdyne segment is strategically critical: it supplies propulsion and interceptors to the U.S. government and primes, meaning the company participates directly in missile and interceptor production expansion plans.

Two fundamental drivers matter:

  • Defense procurement stimulus: Policy moves and geopolitical friction have driven fresh funding commitments for missile defense, interceptors and munitions. Media coverage on 08/10/2026 and 07/31/2026 highlighted seven-year agreements and urgent capacity increases in missiles and interceptors - a direct benefit to L3Harris’ propulsion and missile systems exposure.
  • Product mix and cash conversion: L3Harris mixes high-margin electronic systems and prime integration work with Aerojet’s asset-heavy propulsion business. That combination produces strong free cash flow - nearly $2.8 billion - enabling dividends, buybacks and balance-sheet flexibility to scale production.

Supporting numbers (what the accounts tell us)

Key financials and balance-sheet signals are constructive:

  • Market capitalization about $55.6 billion.
  • Reported earnings per share around $9.99, translating into a trailing P/E in the high-20s (roughly 28x).
  • Free cash flow approximately $2.808 billion.
  • Return on equity roughly 9.36% and return on assets ~4.33%.
  • Leverage moderate - debt-to-equity in the neighborhood of 0.55; current ratio about 1.20.
  • Dividend: quarterly payout of $1.25 per share (ex-dividend scheduled 09/04/2026) and yield around ~1.7%.
  • Trading range: 52-week high $379.23 (03/02/2026) and low $262.68 (07/30/2026); current price sits near the 10- and 20-day averages, with a neutral RSI (~47) and a slightly bullish MACD histogram.

Valuation framing

At ~28x trailing earnings and an enterprise value near $62.9 billion, L3Harris is not inexpensive. But valuation needs context: the company converts revenue into free cash efficiently (FCF margin supports the multiple) and carries a moderate capital structure. If the market starts to price multi-year production agreements and backlog conversion into 2027-2028 revenue, the multiple could expand further, especially for a company that also pays a modest dividend and has buyback optionality. In short: you pay for quality and predictable government cash flow here; the question is whether growth from missile and munitions programs justifies a re-rating from current multiples.

Technical and flow cues

Volume trends show steady institutional activity - 2-week average daily volume near 1.9 million shares historically and current average around 1.5 million. Short interest and short-volume prints spiked around the July low, then subsided, indicating some short-covering may have already occurred. RSI near 47 suggests no immediate overbought condition; MACD shows a small bullish histogram - momentum is neutral-to-constructive. This is supportive for a tactical entry with defined risk control.

Trade plan (actionable)

Trade direction: Long

Entry price: 288.17

Stop loss: 268.00

Target price: 340.00

Time horizon: long term (180 trading days)

Rationale: Entering at the market price of $288.17 captures the current pullback after the summer consolidation. Set a stop at $268.00 — below the late-July low (~$262.68) to avoid being stopped by short-lived volatility while still limiting downside. The primary target of $340.00 is achievable within a 180 trading-day window if multi-year procurement contracts and backlog conversion accelerate revenue and margins; that target sits well below the 52-week high, giving room for appreciation while respecting historical resistance levels.

If you prefer a staged approach, consider an intermediate target at $318.00 into a mid-term timeframe (45 trading days) to lock in gains should headline-driven rallies materialize sooner.

Catalysts (what to watch)

  • Government procurement announcements and funding allocations tied to missile/interceptor production (recent reports 08/10/2026 and 07/31/2026 are precursors).
  • Quarterly earnings and guidance updates that explicitly call out Aerojet Rocketdyne production ramp, margin expansion or contract wins.
  • Large defense prime awards where L3Harris is a critical subsystem supplier - these tend to move multiples when they show durable pipeline growth.
  • Macro risk events that accelerate defense spending or create near-term urgency for interceptors, loitering munitions, and battlefield communications.

Risks and counterarguments

At least four meaningful risks could derail this trade:

  • Budget and political risk: Defense funding is ultimately political. Multi-year appropriations can be delayed, scaled back, or reprioritized, and that would slow backlog conversion.
  • Execution risk and supply chains: Ramping production of propulsion and missile systems is capital and supply-chain intensive. Cost overruns, supplier delays, or manufacturing problems at Aerojet Rocketdyne could compress margins and delay revenue recognition.
  • Valuation compression: With a P/E near 28x, the company is vulnerable to multiple contraction if broader markets or defense multiples de-rate, or if earnings miss expectations.
  • Concentration of government customers: Heavy reliance on U.S. government programs means contract awards, protests or program restructuring have outsized impact on revenue timing and predictability.

Counterargument: Some investors will argue L3Harris is already priced for defense growth - 28x earnings isn't cheap for an industrial with mid-single-digit ROE - and that the market has already baked in missile ramp visibility given spring highs near $379. That’s a fair point; if you believe fiscal constraints will cap procurement increases or that execution risk at Aerojet is underappreciated, the multiple looks aggressive. I acknowledge that risk and build it into a disciplined stop-loss and an explicit target tied to backlog conversion. A miss on guidance would be a clear red flag and would likely force a reassessment.

What would change my mind

I would downgrade this trade if any of the following occur:

  • Quarterly guidance that shows material slippage in Aerojet Rocketdyne production or calls out persistent supply-chain or quality problems.
  • Clear signs of U.S. procurement reprioritization away from missile defense and propulsion to other program areas, reducing near-term spend visibility.
  • A sustained breakdown below $268 with expanding volume that suggests broader distribution rather than a short-term dip—this would invalidate the technical setup and force exit.

Conclusion

Buy L3Harris at $288.17, with a stop at $268.00 and a primary target of $340.00 over a long-term window (180 trading days). The case is straightforward: durable backlog in missiles, sensors and battlefield communications combined with strong free cash flow and manageable leverage make LHX a pragmatic way to play defense procurement tailwinds. The trade balances upside from program ramps with disciplined downside protection. Monitor contract-level disclosures and guidance closely - they are the clearest early indicators of whether the market should re-rate the stock higher or re-price execution risk.

Risks

  • Defense funding is subject to political cycles and reprioritization which can delay or reduce procurement.
  • Execution and supply-chain issues at Aerojet Rocketdyne could delay production ramps and compress margins.
  • The stock trades in the high-20s P/E; multiple contraction on earnings misses would be painful.
  • Concentration on government customers creates program timing and award-risk sensitivity.

More from Trade Ideas

Colony Bankcorp Looks Cheap After a Record Year — A Tactical Long with Defined Risk Aug 10, 2026 Northern Star: Capex Peak Turns Into a Processing Moat and Free Cash Flow Catalyst Aug 10, 2026 Buy Corvus Ahead of Soquelitinib Milestones - Long Trade into Clinical Readouts Aug 10, 2026 TYRA Binary Play: SURF302 Readout Could Re-rate a $1.6B Precision-Oncology Story Aug 10, 2026 Amazon: Stunning Earnings Reaffirm Growth Thesis - Tactical Long with Defined Risk Aug 10, 2026